PTC Therapeutics Inc (PTCT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $68.10
• Market Cap: $5.44B
• P/E Ratio: 8.02
• EPS: $8.45
• 52-Week High: $87.50
• 52-Week Low: $35.95

Market Sentiment

PTC Therapeutics Inc currently has a Neutral sentiment score of -0.03.

About PTC Therapeutics Inc

PTC Therapeutics, Inc. is a pioneering biopharmaceutical firm based in South Plainfield, New Jersey, dedicated to creating innovative therapies for rare genetic disorders. Leveraging its expertise in RNA modulation and small molecule therapeutics, PTC has developed a robust pipeline of advanced product candidates aimed at addressing significant unmet medical needs. The company's strategic focus on transformative treatments positions it as a key player in the rare disease space, driving advanc...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for PTC Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PTCT pay dividends?

PTC Therapeutics Inc (PTCT) does not currently pay a regular dividend.

What is PTCT's P/E ratio?

PTC Therapeutics Inc has a price-to-earnings (P/E) ratio of 8.02.

What is PTCT's market cap?

PTC Therapeutics Inc (PTCT) has a market capitalization of $5.44B with a current stock price of $68.10.